Best MeV. Best , 25 MeV

Similar documents
CLINICALLY USEFUL RADIONUCLIDES:

PRODUCTION OF RADIOISOTOPES FOR IMAGING AND THERAPY AT LOW ENERGY

Isotope Production for Nuclear Medicine

Radiotracers for Early Diagnosis - ReSearching for a Better Life!

Best Particle Therapy, Inc. is Developing a Highly Revolutionary New Treatment for Cancer Therapy

Fusion Gamma radiation Half-life Radioactive tracer

The isotope revolution that can change imaging and therapy

Nuclear Radiation. Natural Radioactivity. A person working with radioisotopes wears protective clothing and gloves and stands behind a shield.

Low Energy Medical Isotope Production. Naomi Ratcliffe IIAA, University of Huddersfield UK

Radiochemistry and Radiopharmacy III

Isotope Production at Brookhaven National Laboratory. Leonard F. Mausner, Brookhaven National Laboratory, Upton, NY. Introduction

Positron Emission Tomography Dr. William C. Uhland Tyco-Mallinckrodt Pharmaceuticals, Maryland Heights, Missouri, USA

PANEL DISCUSSION. Radionuclides and Health A promising future! OCTOBER 14-16, 2014 PARIS LE BOURGET FRANCE

Differentiating Chemical Reactions from Nuclear Reactions

Radiopharmaceuticals for Nuclear Cardiac Imaging: Generator Systems for Tc-99m and Rb-82. Charles W. Beasley, Ph.D. Associate Professor of Radiology

PHY138Y Nuclear and Radiation Section

Radiochemistry in nuclear medicine


Medical Applications of Nuclear Radiation and Isotopes

Relevance of IsoDAR and DAEδALUS to Medical Radioisotope Production

RADIOPHARMACEUTICALS

12/1/17 OUTLINE KEY POINTS ELEMENTS WITH UNSTABLE NUCLEI Radioisotopes and Nuclear Reactions 16.2 Biological Effects of Nuclear Radiation

Radionuclide production

Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA ramsey

State Atomic Energy Corporation Rosatom Russian Radiation Technologies: opportunities to success

Year 12 Notes Radioactivity 1/5

Nuclear Medicine RADIOPHARMACEUTICAL CHEMISTRY

Radionuclide Imaging MII Positron Emission Tomography (PET)

AEPHY: Nuclear Physics Practise Test

Bases of radioisotope diagnostic methods

International Workshop PSD-11 Delft. Clive Naidoo (PhD Chemistry) Dept Head: Radionuclide Production ithemba LABS South Africa

NSAC Isotopes Subcommittee Meeting January 20, 2015 Erin Grady, MD Society of Nuclear Medicine and Molecular Imaging

1. This question is about the Rutherford model of the atom.

Nuclear Medicine Treatments and Clinical Applications

Imaging: PET and SPECT

TRIUMF TR13. Date form last updated: 2016 May 29. Completed by: David Prevost. 1. Cyclotron Facility Contact info. Institute (name/address):

C2-05: Creation of national standards for some emerging pharmaceutical radionuclides to ensure the radioprotection of patients and medical staffs

Chapter. Nuclear Chemistry

Supervised assessment: Ionising radiation

Radioisotopes and PET

This Week. 3/23/2017 Physics 214 Summer

THE PURIFICATION AND THE QUALITY CONTROL OF 68 Ga ELUATES FROM 68 Ge/ 68 Ga GENERATOR *

Nuclear medicine and Radiation technologies

Number of protons. 2. What is the nuclear symbol for a radioactive isotope of copper with a mass number of 60? A) Cu

1st Faculty of Medicine, Charles University in Prague Center for Advanced Preclinical Imaging (CAPI)

Atomic Notation (or Nuclear Symbol): Shorthand for keeping track of protons and neutrons in the nucleus

Applications for Industry and Environment. Radioisotope and Radiation Technology. International Atomic Energy Agency

Radiopharmacy. Prof. Roger Schibli Department of Chemistry and Applied Biosciences ETHZ Center for Radiopharmaceutical Science ETH-PSI-USZ

Essentials of nuclear medicine

Science 10 Radioactivity Review v3

Lecture 11. Half-Lives of Various Nuclides. Radioactive decays are all first order processes. Professor Hicks Inorganic Chemistry (CHE152)

Center for Design and Synthesis of Radiopharmaceuticals for Molecular Targeting CERAD on the Polish Roadmap for Research Infrastructures

NUCLEAR PHYSICS FOR MEDICINE. How nuclear research is improving human health

THE PHYSICS OF MEDICAL IMAGING

Introduction to Radiopharmaceutical chemistry. (Lecture

SCIENCE. Understanding the Radiopharmaceutical Drug Supply Problem: Session 1. U.S. DOE Isotope Program T DOE. Disclosures

Isotope Production from Compact Neutron Sources. ~ 10 6 n/sec. Danish CANS workshop Mikael Jensen

Medical Physics. Nuclear Medicine Principles and Applications

Summary of NSAC-Isotope Subcommittee Report, 2015

This Week. 7/20/2016 Physics 214 Spring

EPFL SB - 2/4 1

Activities from Cyclotron facility at German Cancer Research Center (DKFZ), Heidelberg

General, Organic, and Biological Chemistry, 3e (Frost) Chapter 2 Atoms and Radioactivity. 2.1 Multiple-Choice

Course Objectives Medical Uses for Radiation... 7

Consider a. Collaboration. Do More with MURR. University of Missouri Research Reactor Center

Outline Chapter 14 Nuclear Medicine

III. Proton-therapytherapy. Rome SB - 2/5 1

LIFTING HANDLE SUPPORT LUCITE TUBE GLASS COLUMN. VOLUME - 20 ml RETAINER. ALUMINA PACKING 10g (Al ) GLASS FRIT

COMMITTEE FOR HUMAN MEDICINAL PRODUCTS (CHMP) GUIDELINE ON RADIOPHARMACEUTICALS

RPR 29 CYCLOTRON RADIOCHEMISTRY LABORATORY

KIVI 9 Oct 2015 Fysische Beeldtechnieken 18 feb

Radiopharmaceuticals for Nuclear Medicine and Oncology The Central Role of Chemistry

Nuclear Medicine: Physics and Imaging Methods (SPECT and PET)

RADIOCHEMICAL METHODS OF ANALYSIS

Technical Reports SeriEs No Cyclotron Produced Radionuclides: Principles and Practice

Synthesis and stability of [ 77 Br]-m-Bromobenzylguanidine ( 77 Br-MBBG)

I. Project for Heavy Charged-particle Beam Multi-purpose Use

Radiochemistry and Radiopharmacy IV

69 Ga Ga

Unit 13: Nuclear Chemistry

REPORT. of the. Improved High Current Liquid and Gas Targets for Cyclotron Produced Radioisotopes

Radioactivity, Radionuclides, and Radiopharmaceuticals

Positron Emission Tomography Basics: Radiochemistry. N. Scott Mason, Ph.D. Radiochemist University of Pittsburgh PET Facility

Introduction to SPECT & PET TBMI02 - Medical Image Analysis 2017

REVIEW OF COMPACT COMMERCIAL ACCELERATOR PRODUCTS AND APPLICATIONS

D) g. 2. In which pair do the particles have approximately the same mass?

The new BR2 Reactor Perspectives for Radioisotope Production

ICTP-IAEA Joint Workshop on Nuclear Data for Science and Technology: Medical Applications. 30 September - 4 October, 2013

Atomic Structure. The nuclear atom Electron Configuration. Ms. Thompson - SL Chemistry Wooster High School. Wednesday, July 15, 15

Adriano Duatti Department of Chemical and Pharmaceutical Sciences University of Ferrara Via L. Borsari, 46, Ferrara, Italy

Tomography is imaging by sections. 1

6. Radioactive Sources and IAEA Course Catalog

PRODUCTION AND QUALITY CONTROL OF RADIOPHARMACEUTICALS

Krotov S.A., postgraduate student, Institute of chemistry SPbSU, Radiochemical Department

Nuclear Chemistry. Chapter 23

Stable isotope. Relative atomic mass. Mole fraction 203 Tl Tl Thallium isotopes in Earth/planetary science

Joint ICTP-IAEA School of Nuclear Energy Management August Present and Future (non-power) Nuclear applications

Chapter 2. Atomic Structure and Nuclear Chemistry. Atomic Structure & Nuclear Chemistry page 1

Isotope Production at High Energy Leonard Mausner

SL Chemistry. Monday September 21st Monday, September 21, 15

Transcription:

Best 15 15 MeV 400 µa Best 25 20, 25 MeV 400 µa Best 28u/35 20, 28 35 15 MeV 400 1000 µa Best 70 70 35 MeV 700 µa 2014 Best Cyclotron Systems Best Cyclotron Systems 8765 Ash St., Unit 7, Vancouver, BC V6P 6T3 Canada phone 604 681 3327 fax 604 681 3357 www.bestcyclotron.com v7_06252014_web

The Best Family of PET/SPECT/Research Cyclotrons 15, 25, 28u/35 & 70 MeV Best Cyclotron Systems and TeamBest provide turnkey systems that not only include a cyclotron specific to your isotope requirements but also targets, automated radiochemistry, infrastructure, operations, and maintenance support. As consistent supplies of radioisotopes become more uncertain, particularly for reactor-supplied isotopes, the Best family of cyclotrons provides a Total Solution for the medical community that is less dependent on unreliable sources. Best 15 Best 28u/35 Best 25 Best 70

Isotope Production Capabilities Best 15 Isotopes PET Isotope Carbon-11 Nitrogen-13 Oxygen-15 Fluorine-18 aqueous Fluorine-18 gas Copper-64 Iodine-124 Application Broad Substitution Ammonia: blood flow Blood flow, volume, oxygen utilization FDG mainly, many others Radiolabeling from gas phase Integration through chelation chemistry Monoclonal antibodies SPECT Isotope Gallium-67 Technetium-99m Application Fe analog, inflammatory lesions Many Therapeutic Isotope Palladium-103 Application Interstitial implants, brachytherapy Specifications within are subject to change.

Isotope Production Capabilities Best 25/28u/35 Isotopes Isotope Application Iodine-123 Low dose imaging agent, replacing I 131 Indium-111 Gallium-68 (generator) Thallium-201 Krypton-81m (generator) Blood cell labeling Blood-brain barrier integrity, tumor localization Myocardium functional assessment Gas for ventilation imaging or in solution for perfusion imaging Plus all the isotopes the Best 15 can produce Best 70 Isotopes Isotope Rubidium-82 (generator) Application Diagnosis of coronary artery disease, coronary stenosis, myocardial infarction imaging, viability, collateral function and cardiomyopathy Iodine-123 Low dose imaging agent, replacing I 131 Copper-67 Krypton-81m (generator) Used in radiotherapy by accumulation in tumour tissue using monoclonal antibodies Used either in gaseous form for ventilation imaging or in solution for perfusion imaging Research: Physics, chemistry, Radioactive Ion Beam, activation energy, etc. Specifications within are subject to change.

Isotope Production Capabilities Summary Cyclotron Energy (MeV) Isotopes Produced Best 15 15 F 18, Tc 99m, C 11, N 13, O 15, Cu 64, Ga 67, I 124, Pd 103 Best 25 20, 25 Best 15 + I 123, In 111, Ge 68 /Ga 68 Best 28 Upgradeable 20, 28 Best 15 + I 123, In 111, Ge 68 /Ga 68 Best 35 35 15 Greater production of Best 15, 25 isotopes plus Tl 201, Rb 81 /Kr 81 Best 70 70 35 Sr 82 /Rb 82, I 123, Cu 67, Kr 81 + research Radioisotope, radiochemical, and radiopharmaceutical production requires targets, chemistry, QC, documentation, and packaging for the radioproducts to be shipped and used. Teambest has developed this array of radiopharmacy support so that routine steps and protocols may be obtained from TeamBest and its broad base of service and allows rapid deployment of radiochemicals and radiopharmaceuticals after facility commissioning. The cyclotrons and production processes are tailored to each application. Specifications within are subject to change.

Best 15 MeV Cyclotron Best 15

Ideal for FDG & Tc-99m Supply Best 15 15 MeV fixed energy H - cyclotron External ion source 400 µa extracted proton beams 2 simultaneous extracted beams 4 target positions The B15 is designed for a small pharmacy that is dedicated to the creation of Positron Emitters (PET). Though the principal radioisotope, F 18, is amply produced by the B15, the proton bombarding energy is adequate for the production of the other positron emitters in large amounts. In particular, C 11 and N 13 are available in large quantities and high specific activity. The high beam current of the B15 also permits low contaminant Tc 99m in quantities that will serve a large urban population from a centralized radiopharmacy. The 15 MeV energy of the B15 also allows smaller amounts of target material with the corresponding production cost economy.

Best 25 MeV Cyclotron Best 25

For a Broader Range of Isotopes Best 25 25 and 20 MeV fixed energy H - cyclotron 400 µa extracted proton beams 2 simultaneous extracted beams 4 target positions The B25 is an entry level cyclotron that produces the full collection of PET isotopes but in addition delivers small quantities of some single photon emitters (SPECT). It was designed for groups that are focused on delivering clinical trial quantities of radiopharmaceuticals from a central location (e.g. I 123 labeled drugs), while still providing the standard PET drugs. The small footprint and limited beam current provides an opportunity for specific radiopharmaceutical production.

Best 28u/35 MeV Cyclotron Best 28u/35 The B28 provides complete access to the PET isotopes and offers access to a broad range of single photon emitters (SPECT). When large quantities of SPECT radioisotopes are required then the cyclotron energies of the B28 are matched to the nuclear physics yields and the processing requirements. The B28 supports regional supply of both PET and SPECT radiopharmaceuticals. There is an upgrade path to a high current B35 that provides capability for National and International demands. Both the larger nuclear physics cross sections at higher energies for some radioisotopes as well as the higher current provides a single source for specific radiopharmaceuticals and an international demand.

The World s ONLY Upgradeable Cyclotron Best 28u 28 and 20 MeV fixed energy H - cyclotron 400 µa extracted proton beams 2 simultaneous extracted beams 4 target positions Fully upgradeable e to Best 35 Best 35 35 15 MeV variable energy H - cyclotron 1000 µa extracted proton beams 2 simultaneous extracted beams Up to 6 independent beam lines and target positions

Best 70 MeV Cyclotron Best 70 Best 70 70 35 MeV variable energy H - cyclotron 700 µa extracted proton beams 2 simultaneous extracted beams Multiple independent beam lines and target positions

Ideal for Sr-82/Rb-82 Supply & Research The B70 cyclotron provides a platform for both radioisotope generator parents (e.g. Sr 82 ) and therapy radioisotopes (Cu 67 ). The variable energy between 35 and 70 MeV provides access to single photon emitters as well. Both generator parents and therapy radioisotopes have long half-lives, which result in lower yields per microamperes. Longer dedicated production runs are required but that is balanced by the large International distribution opportunity. The B70 is designed for high current production and the targetry supplied with the cyclotron is matched to the international requirements.